IP Library Granted Patent US 12686854
Granted Patent B2
US 12686854 · App. 17/794,299 · Granted Jul 21, 2026

Method for enhancing secretory function of mesenchymal stem cells and application thereof

Inventors: Shidou Zhao (Jinan, CN); Zijiang Chen (Jinan, CN); Yingying Qin (Jinan, CN); Wenlin Jiao (Jinan, CN)
Assignee: SHANDONG UNIVERSITY
C12N5/0668A61K35/28A61P15/00C12N2501/905
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12686854
App. No.
17/794,299
Granted
Jul 21, 2026
Kind
B2
Abstract

A method for enhancing the secretory function of mesenchymal stem cells and application thereof, belonging to the field of biotechnology. The present invention finds that the secretory function of umbilical cord mesenchymal stem cells (UCMSCs) can be remarkably promoted by pretreating the UCMSCs in vitro using sodium hyaluronate (HA), including increasing the secretion of cytokines such as HGF, SCF, EGF and VEGF, promoting activation of the PI3K-AKT signaling pathway and enhancing the repair of injury.

Claims (10)

1 . A method of enhancing secretory function of mesenchymal stem cells comprising administering a composition consisting of sodium hyaluronate to the mesenchymal stem cells, wherein:

the mesenchymal stem cells are human umbilical cord mesenchymal stem cells;

the concentration of sodium hyaluronate is 0.1-0.3 mg/ml;

the composition is administered for 3 to 5 days; and

the administration results in promoting the secretion of cytokines from the mesenchymal stem cells.

2 . The method of claim 1 , wherein the concentration of sodium hyaluronate sodium is 0.3 mg/mL.

3 . The method of claim 1 , wherein the composition is administered for 5 days.

4 . The method according to claim 1 , wherein, following the administration of the composition, the mesenchymal stems cells promote repair of an injury by activating of the PI3K-AKT signaling pathway through a paracrine mechanism.

5 . The method according to claim 4 , wherein the injury is ovarian tissue injury.

6 . The method according to claim 1 , wherein the cytokines comprise HGF, SCF, EGF and VEGF.